Clinical Trial Update: Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pBI-11 delivered by electroporation for HPV16/18-positive patients; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• pBI-11

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: HPV Infection | Phase 2 | Status: NOT_YET_RECRUITING